These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 11290814)

  • 1. Anergy induction by dimeric TCR ligands.
    Appel H; Seth NP; Gauthier L; Wucherpfennig KW
    J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells.
    Appel H; Gauthier L; Pyrdol J; Wucherpfennig KW
    J Biol Chem; 2000 Jan; 275(1):312-21. PubMed ID: 10617620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
    J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
    Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
    J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific apoptosis in immortalized T cells by soluble MHC class II-peptide complexes.
    Arimilli S; Mumm JB; Nag B
    Immunol Cell Biol; 1996 Feb; 74(1):96-104. PubMed ID: 8934660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
    Zhang X; Tang Y; Sujkowska D; Wang J; Ramgolam V; Sospedra M; Adams J; Martin R; Pinilla C; Markovic-Plese S
    Eur J Immunol; 2008 May; 38(5):1297-309. PubMed ID: 18412170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation.
    Wang C; Mooney JL; Meza-Romero R; Chou YK; Huan J; Vandenbark AA; Offner H; Burrows GG
    J Immunol; 2003 Aug; 171(4):1934-40. PubMed ID: 12902496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The magnitude of TCR engagement is a critical predictor of T cell anergy or activation.
    Mirshahidi S; Ferris LC; Sadegh-Nasseri S
    J Immunol; 2004 May; 172(9):5346-55. PubMed ID: 15100274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera.
    Thomas S; Kumar R; Preda-Pais A; Casares S; Brumeanu TD
    J Immunol; 2003 Jun; 170(12):5981-92. PubMed ID: 12794125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation.
    Matyszak MK; Denis-Donini S; Citterio S; Longhi R; Granucci F; Ricciardi-Castagnoli P
    Eur J Immunol; 1999 Oct; 29(10):3063-76. PubMed ID: 10540317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
    Moisini I; Nguyen P; Fugger L; Geiger TL
    J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein.
    Gauthier L; Smith KJ; Pyrdol J; Kalandadze A; Strominger JL; Wiley DC; Wucherpfennig KW
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11828-33. PubMed ID: 9751750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
    Chang JW; Mechling DE; Bächinger HP; Burrows GG
    J Biol Chem; 2001 Jun; 276(26):24170-6. PubMed ID: 11319230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).
    Vergelli M; Hemmer B; Utz U; Vogt A; Kalbus M; Tranquill L; Conlon P; Ling N; Steinman L; McFarland HF; Martin R
    Eur J Immunol; 1996 Nov; 26(11):2624-34. PubMed ID: 8921948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
    Wucherpfennig KW; Sette A; Southwood S; Oseroff C; Matsui M; Strominger JL; Hafler DA
    J Exp Med; 1994 Jan; 179(1):279-90. PubMed ID: 7505801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules.
    Nag B; Arimilli S; Mukku PV; Astafieva I
    J Biol Chem; 1996 Apr; 271(17):10413-8. PubMed ID: 8626615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide.
    Wucherpfennig KW; Hafler DA
    Ann N Y Acad Sci; 1995 Jul; 756():241-58. PubMed ID: 7544075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of T cell anergy by low numbers of agonist ligands.
    Korb LC; Mirshahidi S; Ramyar K; Sadighi Akha AA; Sadegh-Nasseri S
    J Immunol; 1999 Jun; 162(11):6401-9. PubMed ID: 10352253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.